Related Experiment Video
Updated: Sep 23, 2025

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Annexin A protein family in atherosclerosis
Yong-Zhen Li1, Yan-Yue Wang1, Liang Huang2
1Institute of Cardiovascular Disease, Key Lab for Arteriosclerology of Hunan Province, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, People's Republic of China.
Insights
Annexin A (AnxA) proteins are key drivers of atherosclerosis development. Targeting AnxA family members may offer a novel strategy to prevent cardiovascular ischemic events.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Immunology
Background:
- Atherosclerosis is a chronic vascular pathology causing most cardiovascular ischemic events.
- It involves endothelial dysfunction, inflammation, lipid accumulation, and cell death.
- Annexin A (AnxA) proteins regulate inflammation and cell signaling.
Purpose of the Study:
- To discuss the roles of AnxA1, AnxA2, AnxA5, and AnxA7 in atherosclerosis.
- To explore the mechanisms underlying AnxA involvement in atherogenesis.
- To propose AnxA proteins as therapeutic targets for atherosclerosis.
Main Methods:
- Literature review of AnxA family proteins in atherosclerosis.
- Analysis of AnxA functions in cellular processes relevant to atherosclerosis.
- Synthesis of evidence on AnxA involvement in atherogenesis.
Main Results:
- AnxA1, AnxA2, AnxA5, and AnxA7 play significant roles in atherosclerosis development.
- These AnxA proteins are involved in inflammation, cell signaling, and cell fate.
- Evidence suggests AnxAs actively drive atherosclerosis progression.
Conclusions:
- AnxA proteins are identified as critical drivers of atherosclerosis.
- Targeting AnxA expression or function presents a potential therapeutic avenue.
- Intervention against AnxA family may prevent atherosclerosis progression and cardiovascular events.
Abstract:
Atherosclerosis, a silent chronic vascular pathology, is the cause of the majority of cardiovascular ischaemic events. Atherosclerosis is characterized by a series of deleterious changes in cellularity, including endothelial dysfunction, transmigration of circulating inflammatory cells into the arterial wall, pro-inflammatory cytokines production, lipid accumulation in the intima, vascular local inflammatory response, atherosclerosis-related cells apoptosis and autophagy. Proteins of Annexin A (AnxA) family, the well-known Ca2+ phospholipid-binding protein, have many functions in regulating inflammation-related enzymes and cell signaling transduction, thus influencing cell adhesion, migration, differentiation, proliferation and apoptosis. There is now accumulating evidence that some members of the AnxA family, such as AnxA1, AnxA2, AnxA5 and AnxA7, play major roles in the development of atherosclerosis. This article discusses the major roles of AnxA1, AnxA2, AnxA5 and AnxA7, and the multifaceted mechanisms of the main biological process in which they are involved in atherosclerosis. Considering these evidences, it has been proposed that AnxA are drivers- and not merely participator- on the road to atherosclerosis, thus the progression of atherosclerosis may be prevented by targeting the expression or function of the AnxA family proteins.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Inflammation
Aneurysm I: Introduction
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Atherosclerosis III: Management

